Comparison of Human Papillomavirus Type 16 L1 Chimeric Virus-Like Particles versus L1/L2 Chimeric Virus-Like Particles in Tumor Prevention

Publisher： Karger

E-ISSN： 1423-0100|45|4-6|300-307

ISSN： 0300-5526

Source： Intervirology, Vol.45, Iss.4-6, 2003-01, pp. : 300-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virus-like particles as a potential vaccine for human papillomavirus

By Ault Kevin A.  

Papillomavirus Report, Vol. 14, Iss. 2, 2003-03 ,pp. : 47-51

Maney Publishing

Access to resources Recommend Favorite

Evaluation of HBs, HBc, and frCP Virus-Like Particles for Expression of Human Papillomavirus 16 E7 Oncoprotein Epitopes

By  

Intervirology, Vol. 45, Iss. 1, 2002-04 ,pp. : 24-32

Karger

Access to resources Recommend Favorite

Virus-Like Particles as a Modular System for Novel Vaccines

By  

Intervirology, Vol. 45, Iss. 4-6, 2003-01 ,pp. : 212-217

Karger

Access to resources Recommend Favorite

Production of Human Parvovirus 4 VP2 Virus-Like Particles in Yeast and Their Evaluation as an Antigen for Detection of Virus-Specific Antibodies in Human Serum

By  

Intervirology, Vol. 56, Iss. 5, 2013-08 ,pp. : 271-277

Karger

Access to resources Recommend Favorite

Generation of Recombinant Virus-Like Particles of Human and Non-Human Polyomaviruses in Yeast Saccharomyces cerevisiae

By  

Intervirology, Vol. 45, Iss. 4-6, 2003-01 ,pp. : 308-317

Karger

Access to resources Recommend Favorite